Knocking down BRG1 expression significantly inhibited colon cancer cell proliferation (Figure 3E, **P < 0.01), cancer cell clonogenicity (Figure 3F, **P < 0.01) and invasive ability (Figure 3G, **P < 0.01). Here, SMARCA4 is linked to colonic neoplasm.